PG-011 Nasal Spray

· Prime Gene Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PG-011 Nasal Spray, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis [Phase 3]

See pricing